CaniVac DHPPL®

Product Information

01Indication

For active immunization of dogs as an aid in the control and prevention of canine distemper, infectious canine hepatitis, parvovirus, infectious tracheobronchitis, and leptospirosis caused by canine distemper virus, canine adenovirus type 2, canine parvovirus, canine parainfluenza virus, Leptospira canicola, and L. icterohaemorrhagiae.

02Composition

• CaniVac DHPP: Canine distemper virus – 30%, Canine adenovirus type 2 – 10%, Canine parvovirus – 20%, Canine parainfluenza virus – 20%, Stabilizer – 20%.
• CaniVac Lepto: Leptospira canicola – 0.5ml, Leptospira icterohaemorrhagiae – 0.5ml, Thimerosal – 0.01%

03Administration and Dosage

• Dilute one dose of CaniVac DHPP with one dose of CaniVac LEPTO (1ml) and administer subcutaneously or intramuscularly.
• The initial dose should be given at 6 to 8 weeks of age, followed by boosters every 2 to 4 weeks, with the series ending in a final dose given at 16 weeks of age or older.

04Presentation

Box of 10 doses: DHPP 10 vials + LEPTO 10 vials

05Target Species

Dogs

06Storage

Store in a dark and cool place between 2–8°C.